Loss to Follow-up and Death Among Individuals With Newly Diagnosed Human Immunodeficiency Virus Receiving Dolutegravir-Based First-Line Antiretroviral Treatment in Eastern Ethiopia: Implications for 95% United Nations Targets

BACKGROUND: Loss to follow-up (LTFU) and death are unfavorable outcomes of human immunodeficiency virus (HIV) treatment. This study aimed to identify the predictors of LTFU and death among individuals with newly diagnosed HIV receiving dolutegravir (DTG)–based first-line antiretroviral treatment (AR...

Descripción completa

Detalles Bibliográficos
Autores principales: Gemechu, Abdella, Mihret, Adane, Aseffa, Abraham, Howe, Rawleigh, Seyoum, Berhanu, Mulu, Andargachew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10638489/
https://www.ncbi.nlm.nih.gov/pubmed/37953815
http://dx.doi.org/10.1093/ofid/ofad522

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10638489/
https://www.ncbi.nlm.nih.gov/pubmed/37953815
http://dx.doi.org/10.1093/ofid/ofad522

Ejemplares similares